Riluzole Powder CAS 1744-22-5 Amyotrophic Lateral Sclerosis Riluzole

• Customization: Available
• Powder: Yes
• Customized: Customized
• Certification: GMP, ISO 9001, USP
• Suitable for: Adult
• State: Powder
• Purity: >99%
• Sample: Available
• OEM: Available
• MOQ: 1kg
• CAS: 1744-22-5
• Keyword: Riluzole
• Keyword 1: Riluzole Powder
• Transport Package: 1kg Foil Bag /25kg Drum
• Specification: 99%
• Trademark: /
• Origin: China
• Production Capacity: 20000

Product Description

Description

As a benzothiazole compound, riluzole is the only drug approved by the FDA for the treatment of amyotrophic lateral sclerosis (ALS). It plays a role mainly by regulating glutamate concentration and acting on ion channels. Riluzole has a wide range of pharmacological effects, such as the regulation of glutamate and its transporters, neuroprotective effect, antidepressant, anti anxiety, analgesia and so on.

Product name	Riluzole
Appearance	White Powder
Specification	99%
Shelf life	2 years when properly stored

Function and Application

Amyotrophic Lateral Sclerosis (ALS) Treatment: Riluzole is primarily prescribed for the treatment of ALS, a progressive neurodegenerative disease. It has been shown to extend survival and slow the progression of functional impairment in some patients.
Neuroprotective Effects: Due to its neuroprotective properties, riluzole is also being studied for potential applications in other neurological conditions, such as stroke and traumatic brain injury, although these uses are still under investigation.
Research Tool: In scientific research, riluzole serves as a valuable tool to investigate the mechanisms of glutamate-mediated neurotoxicity and neuroprotection, aiding in the development of new therapeutic strategies for neurological disorders.